Placebo News and Research

RSS

Are nicotine patches safe for pregnant women?

A £1 million study, being led by a team of multidisciplinary researchers at The University of Nottingham, is to look at whether nicotine replacement skin patches could help pregnant mums to stop smoking.

26 Aug 2004

Prozac helps treat adolescents with depression

The TADS researchers said that major depressive disorder is common, with one in 20 teens affected at varying levels of severity. Like other forms of depression, major depressive disorder has been associated with increased risk of suicidal behavior and with completed suicide.

26 Aug 2004

Pfizer receives approval for acute bipolar mania drug

Pfizer has announced that the U.S. Food and Drug Administration (FDA) has approved the use of its atypical antipsychotic Geodon(R) (ziprasidone HCI) for the treatment of acute bipolar mania including manic and mixed episodes.

23 Aug 2004

Effectiveness of gingko to treat early dementia

Researchers in London are to explore the effectiveness of gingko, a complementary medicine traditionally used to treat circulatory problems, as a treatment for early dementia.

23 Aug 2004

Pfizer drug effectively treats overactive bladder symptoms

Women with mixed incontinence, a combination of overactive bladder and stress incontinence, reported a greater treatment benefit for overactive bladder symptoms from DETROL® LA (tolterodine tartrate extended release capsules) than placebo, according to new study results published in the August issue of Urology.

21 Aug 2004

Nicotine replacement therapy shown to help teenagers and women

In the first study, researchers at the Stanford University School of Medicine have found that the nicotine patch seems to work as well, at least initially, for teens as it does for adults. In addition, the patch, the top delivery form of NRT (followed by gum, an inhaler and a nasal spray) worked equally well with or without supplementation by an anti-depressant given to the teens.

21 Aug 2004

Current information on the use of antidepressants in pediatric patients

The Food and Drug Administration has issued an update to provide health care providers and patients with the most current information on the use of antidepressants in pediatric patients.

21 Aug 2004

People with type 2 diabetes could benefit from atorvastatin

Results of a randomised trial in this week’s issue of THE LANCET suggest that people with type 2 diabetes could benefit from cholesterol-lowering therapy with statins to reduce the risk of cardiovascular disease, even when they do not have high cholesterol concentrations.

20 Aug 2004

Vitamin E has potential benefit in fighting colds in the elderly

Vitamin E supplementation has potential benefit in fighting upper respiratory tract infections such as colds in the elderly, says a study published in the Aug. 18 issue of JAMA.

18 Aug 2004

"Treatment for Adolescents with Depression Study" - a landmark study

The "Treatment for Adolescents with Depression Study" (TADS), reported in this week's Journal of the American Medical Association, is the first multi- center, randomized clinical effectiveness trial to review a combination of treatments for the types of adolescent depression likely to be treated in routine community-based practice settings.

18 Aug 2004

Treatment of child depression most successful with Prozac and cognitive-behavior therapy combination

A new study by researchers at the UT Southwestern Medical Center at Dallas, have found that treatment of child depression was most successful when a combination of Prozac and cognitive-behavior therapy was applied.

18 Aug 2004

Mixed effects for vitamin E against respiratory infections

Vitamin E does not appear to have a beneficial effect on lower respiratory tract infections in elderly nursing home residents, but it may help them ward off upper respiratory tract infections, according to a study in the current issue of the Journal of the American Medical Association.

18 Aug 2004

New guidelines urge early and long-term treatment with Aldosterone blockade therapy

Patients who have had a recent heart attack with ST-elevation (ST-Elevation Myocardial Infarction, or STEMI), complicated by heart failure should be treated with aldosterone blockers according to new guidelines issued recently by the American College of Cardiology (ACC) and the American Heart Association (AHA).

17 Aug 2004

Nasal cream effective in reducing the symptoms of allergic rhinitis

A nasal cream applied to the inside of the nose appears effective in reducing the symptoms of allergic rhinitis, according to an article in the August issue of The Archives of Otolaryngology – Head & Neck Surgery.

16 Aug 2004

Smoking may be on the rise again

The statistics are alarming: About one in five high school seniors smoke cigarettes daily. Yet nearly half a million Americans die prematurely from tobacco-related disease and smoking is projected to in some way kill one third of all smokers.

15 Aug 2004

Scopolamine prevents and relieves motion sickness - but possibly with more adverse effects than alternatives

Researchers from the Cochrane Collaboration have analysed all trials of scopolamine for motion sickness. They found 12 trials, mostly done in healthy young men in the navy.

12 Aug 2004

No adverse side-effects have been observed in clinical trial of SARS vaccine

Sinovac Biotech has announced that all 36 subjects of the Phase I human clinical trial for its inactivated SARS vaccine have now been vaccinated with either SARS vaccine or placebo.

11 Aug 2004

Serious new side effects of performance enhancing drugs

As the countdown continues to the Athens Olympics, a new Australian study by a team of Southern Cross University (SCU) scientists has revealed serious new side effects of performance enhancing drugs.

11 Aug 2004

Wounds on hamsters without companionship don't heal as fast as those on hamsters with companionship

Researchers looked at the effect social contact had on wound healing in stressed hamsters. Results showed that skin wounds healed nearly twice as fast in the hamsters paired with a sibling. These animals also produced less of the stress hormone cortisol than unpaired hamsters.

9 Aug 2004

Clinical trial of lipase inhibitor for the treatment of obesity

Peptimmune, Inc. a privately held biotechnology company, announced that physicians have treated the first participant in a clinical trial to evaluate the safety, tolerability and pharmacokinetics of GT389-255, a lipase inhibitor conjugated to a fat binding polymer for the treatment of obesity.

9 Aug 2004